Alpine Associates Management’s Avanos Medical AVNS Stock Holding History

Alpine Associates Management’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.8M	Buy	+432,621	New	+$10.1M	0.67%	41

Other funds holding AVNS

SRC

Samson Rock Capital London, United Kingdom $45.6M AUM 86.17% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

CIEC

Crédit Industriel et Commercial Paris France, France $1.55B AUM 42.08% 1-Year Est. Return

TMAM

Tokio Marine Asset Management Tokyo, Japan $3.23B AUM 37.2% 1-Year Est. Return

KIM

Kestrel Investment Management San Mateo, California $184M AUM 31.66% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.99% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return

Alpine Associates Management's AVNS Position: Q2 2026 in Review

Alpine Associates Management opened a new position in Avanos Medical (AVNS) in Q2 2026: 432,621 shares worth $10.8M. The stake represents 0.67% of the portfolio and ranks #41 among its holdings.

108 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

Alpine Associates Management held 432,621 shares of Avanos Medical worth $10.8M as of Q2 2026.
Avanos Medical was a new Alpine Associates Management position in Q2 2026.
Avanos Medical made up 0.67% of Alpine Associates Management's portfolio in Q2 2026, its #41 holding.
108 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Alpine Associates Management's 13F filing for Q2 2026, filed 6 Aug 2026.